Algorae Pharmaceuticals Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LVCLF research report →
Price Chart
About the company
Algorae Pharmaceuticals Limited, a company established in 1987 and based in Melbourne, Australia, focuses on pioneering pharmaceutical development. Known as Living Cell Technologies Limited until its rebranding in September 2023, the firm primarily conducts research and innovation in living cell technologies within New Zealand. Its development portfolio includes AI-116, a novel combination treatment pairing donepezil with cannabidiol, designed to address various forms of dementia, such as Alzheimer's disease.
- CEO
- David Richard Hainsworth
- IPO
- 2010
- Employees
- 48
- HQ
- Melbourne, VI, AU
Get TickerSpark's AI analysis on LVCLF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $14.52M
- P/E
- -5.14
- PEG
- 0.06
- P/S
- 0.00
- P/B
- 3.84
- EV/EBITDA
- -4.79
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -132.20%
- ROIC
- -105.43%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-3,255,522
- Net Income
- $-2,809,313-249.9%
- EPS
- $-0.00-200.0%
- OCF Growth
- -343675.5%
- FCF Growth
- -343675.2%
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- -0.03
- RSI (14)
- 39
- Avg Volume
- 789
No earnings-call transcripts are available for LVCLF yet.
- Free Float
- 99.1%
- Shares Outstanding
- 2.03B
- Float Shares
- 2.01B
Our LVCLF coverage
Recent articles, reports, and earnings notes.
No research on LVCLF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LVCLF report →Could quantum computing advances sink Bitcoin?
proactiveinvestors.com · May 18
Algorae completes AI prediction phase for expanded drug combination program
proactiveinvestors.com · May 18
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.